How much can investors make with Arcellx Inc (ACLX) stock in the next 12 months?

Kevin Freeman

Arcellx Inc [ACLX] stock is trading at $85.07, up 3.44%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The ACLX shares have gain 6.67% over the last week, with a monthly amount glided 17.89%, and seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

Arcellx Inc [NASDAQ: ACLX] stock has seen the most recent analyst activity on June 17, 2025, when Citigroup initiated its Buy rating and assigned the stock a price target of $110. Previously, Redburn Atlantic started tracking the stock with Buy rating on October 08, 2024, and set its price target to $109. On September 03, 2024, Cantor Fitzgerald initiated with a Overweight rating. Piper Sandler started tracking the stock assigning a Overweight rating and suggested a price target of $70 on May 31, 2024. Morgan Stanley initiated its recommendation with a Overweight and recommended $81 as its price target on March 07, 2024. Needham reiterated a Buy rating for this stock on January 04, 2024, and upped its price target to $71. In a note dated December 19, 2023, Scotiabank initiated an Sector Outperform rating and provided a target price of $66 on this stock.

Arcellx Inc [ACLX] stock has fluctuated between $47.86 and $107.37 over the past year. Currently, Wall Street analysts expect the stock to reach $83 within the next 12 months. Arcellx Inc [NASDAQ: ACLX] shares were valued at $85.07 at the most recent close of the market. An investor can expect a potential drop of -2.43% based on the average ACLX price forecast.

Analyzing the ACLX fundamentals

Arcellx Inc [NASDAQ:ACLX] reported sales of 56.98M for the trailing twelve months, which represents a drop of -72.41%. Gross Profit Margin for this corporation currently stands at 0.97% with Operating Profit Margin at -3.76%, Pretax Profit Margin comes in at -3.27%, and Net Profit Margin reading is -3.3%. To continue investigating profitability, this company’s Return on Assets is posted at -0.3, Equity is -0.43 and Total Capital is -0.43. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.13.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 82.77 points at the first support level, and at 80.48 for the second support level. However, for the 1st resistance point, the stock is sitting at 86.79, and for the 2nd resistance point, it is at 88.51.

Ratios To Look Out For

For context, Arcellx Inc’s Current Ratio is 3.81. In addition, the Quick Ratio stands at 3.81 and the Cash Ratio stands at 0.51. Considering the valuation of this stock, the price to sales ratio is 82.80, the price to book ratio is 12.01.

Transactions by insiders

Recent insider trading involved MICHELLE GILSON, Officer, that happened on Oct 03 ’25 when 5946.0 shares were purchased. CHIEF MEDICAL OFFICER, Heery Christopher completed a deal on Sep 30 ’25 to sell 21034.0 shares. Meanwhile, CHIEF MEDICAL OFFICER Heery Christopher sold 73.0 shares on Sep 29 ’25.

MZP News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.